Option Therapeutics Inc. (OPTN) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
OPTN Profit Margin, ROE & Profitability Analysis
OPTN vs Healthcare Sector: How Option Therapeutics Inc. Compares
How Option Therapeutics Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Option Therapeutics Inc. Stock Overvalued? OPTN Valuation Analysis 2026
Based on fundamental analysis, Option Therapeutics Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Option Therapeutics Inc. Balance Sheet: OPTN Debt, Cash & Liquidity
OPTN Revenue Growth, EPS Growth & YoY Performance
OPTN SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Option Therapeutics Inc. (CIK: 0002070577)
📋 Recent SEC Filings
❓ Frequently Asked Questions about OPTN
What is the AI rating for OPTN?
Option Therapeutics Inc. (OPTN) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are OPTN's key strengths?
Claude: Analysis in progress.
What are the risks of investing in OPTN?
Claude: Analysis in progress.
What is OPTN's revenue and growth?
Option Therapeutics Inc. reported revenue of N/A.
Does OPTN pay dividends?
Option Therapeutics Inc. does not currently pay dividends.
Where can I find OPTN SEC filings?
Official SEC filings for Option Therapeutics Inc. (CIK: 0002070577) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is OPTN's EPS?
Option Therapeutics Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is OPTN's fundamental grade?
Based on our AI fundamental analysis in July 2026, Option Therapeutics Inc. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is OPTN stock overvalued or undervalued?
Valuation metrics for OPTN: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is OPTN's AI grade for 2026?
Our dual AI analysis gives Option Therapeutics Inc. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is OPTN's free cash flow?
Option Therapeutics Inc.'s operating cash flow is N/A, with capital expenditures of N/A.
How does OPTN compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).